Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Equity - Schedule of All Outstanding Options Activity (Details)

v3.21.2
Shareholders' Equity - Schedule of All Outstanding Options Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
9 Months Ended 12 Months Ended
Oct. 02, 2021
Jan. 02, 2021
Dec. 28, 2019
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Options Outstanding, Beginning Balance 113,900 44,400  
Options Outstanding, Granted 38,000 74,000  
Options Outstanding, Exercised (6,000)    
Options Outstanding, Cancelled/expired/forfeited (25,400) (4,500)  
Options Outstanding, Ending Balance 120,500 113,900 44,400
Weighted Average Exercise Price      
Weighted Average Exercise Price, Beginning Balance $ 11.97 $ 13.31  
Weighted Average Exercise Price, Granted 8.16 3.84  
Weighted Average Exercise Price, Exercised 4.32    
Weighted Average Exercise Price, cancelled/expired/forfeited 8.28 9.45  
Weighted Average Exercise Price, Ending Balance $ 7.52 $ 11.97 $ 13.31
Aggregate Intrinsic Value, Options Outstanding $ 180 $ 78 $ 0
Weighted Average Remaining Contractual Life 7 years 1 month 6 days 7 years 3 years